Human papillomavirus (HPV) is the necessary cause of cervical cancer, the fourth most
common cancer and cause of cancer-related death in females worldwide. HPV also causes …

This paper summarises the position of ESGO and EFC on cervical screening based on
existing guidelines and opinions of a team of lead experts. HPV test is replacing cytology as …

Rebecca B. Perkins, MD, MSc, 1 Richard S. Guido, MD, 2 Philip E. Castle, PhD, 3 David
Chelmow, MD, 4 Mark H. Einstein, MD, MS, 5 Francisco Garcia, MD, MPH, 6 Warner K. Huh …

This report summarizes the epidemiology of human papillomavirus (HPV) and associated
diseases, describes the licensed HPV vaccines, provides updated data from clinical trials …

Importance Evidence on the relative benefits and harms of primary high-risk human
papillomavirus (hrHPV) testing is needed to inform guidelines. Objective To inform the US …

Objective We assessed the age-related prevalence of high risk human papillomavirus (HR-
HPV) genotypes and the genotype-associated risk for high-grade cervical intraepithelial …

The control arm of the phase III VIVIANE (Human PapillomaVIrus: Vaccine Immunogenicity
ANd Efficacy; NCT00294047) study in women> 25 years was studied to assess risk of …

Summary Background In May, 2018, the Director-General of WHO issued a global call to
eliminate cervical cancer as a public health problem, which will involve ambitious screening …

Background: Human papillomavirus (HPV) testing provides a much more sensitive method
of detection for high-grade lesions than cytology, but specificity is low. Here, we explore the …

Introduction: The prevalence of cervical Human Papillomavirus (HPV) infection varies
greatly worldwide and data regarding HPV prevalence and genotypes in China are limited …